1. Home
  2. ATGE vs PCVX Comparison

ATGE vs PCVX Comparison

Compare ATGE & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATGE
  • PCVX
  • Stock Information
  • Founded
  • ATGE 1987
  • PCVX 2013
  • Country
  • ATGE United States
  • PCVX United States
  • Employees
  • ATGE N/A
  • PCVX N/A
  • Industry
  • ATGE Other Consumer Services
  • PCVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATGE Consumer Discretionary
  • PCVX Health Care
  • Exchange
  • ATGE Nasdaq
  • PCVX Nasdaq
  • Market Cap
  • ATGE 4.9B
  • PCVX 4.0B
  • IPO Year
  • ATGE 1991
  • PCVX 2020
  • Fundamental
  • Price
  • ATGE $135.74
  • PCVX $31.23
  • Analyst Decision
  • ATGE Strong Buy
  • PCVX Strong Buy
  • Analyst Count
  • ATGE 3
  • PCVX 8
  • Target Price
  • ATGE $139.00
  • PCVX $114.17
  • AVG Volume (30 Days)
  • ATGE 325.6K
  • PCVX 1.5M
  • Earning Date
  • ATGE 10-28-2025
  • PCVX 11-04-2025
  • Dividend Yield
  • ATGE N/A
  • PCVX N/A
  • EPS Growth
  • ATGE 82.07
  • PCVX N/A
  • EPS
  • ATGE 6.18
  • PCVX N/A
  • Revenue
  • ATGE $1,788,290,000.00
  • PCVX N/A
  • Revenue This Year
  • ATGE $9.21
  • PCVX N/A
  • Revenue Next Year
  • ATGE $6.86
  • PCVX N/A
  • P/E Ratio
  • ATGE $21.86
  • PCVX N/A
  • Revenue Growth
  • ATGE 12.85
  • PCVX N/A
  • 52 Week Low
  • ATGE $71.09
  • PCVX $27.66
  • 52 Week High
  • ATGE $140.12
  • PCVX $121.06
  • Technical
  • Relative Strength Index (RSI)
  • ATGE 52.47
  • PCVX 50.95
  • Support Level
  • ATGE N/A
  • PCVX N/A
  • Resistance Level
  • ATGE $139.93
  • PCVX $33.32
  • Average True Range (ATR)
  • ATGE 3.29
  • PCVX 1.15
  • MACD
  • ATGE -5.24
  • PCVX -1.07
  • Stochastic Oscillator
  • ATGE 97.01
  • PCVX 92.75

About ATGE Adtalem Global Education Inc.

Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: